Global monkeypox cases have passed the 1,000 mark, according to the World Health Organization. Nearly 30 countries have reported cases during the outbreak, though none have reported deaths. (Reuters)
Vertex Pharmaceuticals received a Breakthrough Therapy Designation from the Food and Drug Administration for its kidney disease drug. The grant was supported by the Phase 2 clinical study of inaxaplin in patients with APOL1-mediated focal segmental glomerulosclerosis. (Benzinga)
Biospring Partners closed its $245 million first fund as private markets tensed up. The PE fund, which invests in the life sciences technology sector, was founded in 2020 by Michelle Dipp and Jennifer Lum. (STAT)
If the Supreme Court overturns Roe v. Wade, it could jeopardize LGBTQIA+ rights. “The LGBTQ community relies on reproductive health care. LGBTQ people seek and receive abortions, they seek and receive and use contraception,” explained Cathryn Oakley, an attorney with the Human Rights Campaign. (NBC News)
Bayer’s new oncology head said she wants the company to compete for biotech deals. The conglomerate is aiming to build its pipeline of therapies in the fast-growing field of oncology, anchored by prostate cancer drug Nubeqa. (Bloomberg)
